Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Gains from Investment Securities (2016 - 2022)

Sonoma Pharmaceuticals (SNOA) has 4 years of Gains from Investment Securities data on record, last reported at $163000.0 in Q1 2013.

  • For Q1 2013, Gains from Investment Securities rose 12.41% year-over-year to $163000.0; the TTM value through Mar 2013 reached $624000.0, up 39.29%, while the annual FY2023 figure was $1000.0, 99.87% down from the prior year.
  • Gains from Investment Securities reached $163000.0 in Q1 2013 per SNOA's latest filing, up from $158000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $231000.0 in Q4 2011 and bottomed at -$4000.0 in Q2 2010.
  • Average Gains from Investment Securities over 4 years is $122400.0, with a median of $151500.0 recorded in 2012.
  • Peak YoY movement for Gains from Investment Securities: surged 1550.0% in 2011, then tumbled 31.6% in 2012.
  • A 4-year view of Gains from Investment Securities shows it stood at -$4000.0 in 2010, then skyrocketed by 5875.0% to $231000.0 in 2011, then tumbled by 31.6% to $158000.0 in 2012, then rose by 3.16% to $163000.0 in 2013.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $163000.0 in Q1 2013, $158000.0 in Q4 2012, and $153000.0 in Q3 2012.